Diagnosis → Ophthalmology

Retinitis pigmentosa

A genetic eye disorder characterized by the progressive degeneration of photoreceptor cells in the retina leading to vision loss.

Also known as: Hereditary retinal dystrophy, Pigmentary retinal dystrophy, Rod-cone dystrophy

Etiology

Causes [ycd]

Pathophysiology [ycd]

  1. The affected genes are responsible for critical retinal functions:

    • Phototransduction, the visual cycle, ciliary transport, and photoreceptor structure

  2. Genetic mutation --> Biochemical dysfunction affecting rod photoreceptors

  3. Injury pathways: Apoptosis, light damage, and ciliary transport dysfunction

  4. The result is death of the rod photoreceptors (responsible for low-light vision)

  5. The loss of large numbers of rods --> toxic environment:

    • Retinal pigment epithelium destruction

    • Cone photoreceptor cell death

  6. Clinical manifestation:

    • Visual disturbances

    • Nyctalopia: Loss of night vision

    • Gradual narrowing of the visual fields

    • Tunnel vision

    • Complete vision loss

    • Dyschromatopsia: Loss of accurate color discrimination

    • Loss of visual acuity

    • Photopsia

    • Visual hallucinations

Complications [ycd]

Epidemiology

Prevalence per 100.000 [ycd][fbh][ehc][9ur][wmk]

Default

Epidemiology chart for Prevalence

Symptoms & findings

Symptoms

Bilateral hemianopsia, Blindness, Blurred vision, Night blindness, Photopsia, Scotoma, Visual disturbances

Clinical findings

None listed.

Anamneses

None listed.

Approach

Treatment

  1. There is currently no cure for RP [ycd]

  2. Ongoing research shows promising potential:

    • Gene therapy

    • Stem cell therapy

    • Retinal implants show promise in restoring vision

  3. Management involves to help individuals adapt to their changing vision:

    • Nutritional supplementation, especially with vitamin A

    • Low-vision aids

    • Sun glasses

    • Optimize refraction glasses

    • Orientation

    • Mobility training

  4. Macular edema: topical or systemic carbonic anhydrase inhibitors

  5. Cataracts: Intraocular lens

Differential diagnoses

Age-related macular degeneration, Cytomegalovirus, Drug side effects, Lyme disease, Measles, Retinal artery occlusion, Retinal detachment, Retinitis, Retinoblastoma, Retinopathy, Rubella, Sarcoidosis, Systemic lupus erythematosus, Toxoplasmosis, Trauma, Tuberculosis, Vitamin deficiency


References

[1] O'Neal TB, Tripathy K, Luther EE. Retinitis Pigmentosa. [Updated 2024 Feb 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519518/

[2] Haim M. Epidemiology of retinitis pigmentosa in Denmark. Acta Ophthalmol Scand Suppl. 2002;(233):1-34.

[3] Abbass NJ, Yazji I, Allan KC, Kaelber DC, Talcott KE, Singh RP. Trends and Disparities in the Incidence and Prevalence of Inherited Retinal Diseases in the United States. Am J Ophthalmol. 2025 Nov;279:165-173.

[4] Na KH, Kim HJ, Kim KH, Han S, Kim P, Hann HJ, Ahn HS. Prevalence, Age at Diagnosis, Mortality, and Cause of Death in Retinitis Pigmentosa in Korea-A Nationwide Population-based Study. Am J Ophthalmol. 2017 Apr;176:157-165.

[5] Tsujikawa M, Wada Y, Sukegawa M, Sawa M, Gomi F, Nishida K, Tano Y. Age at onset curves of retinitis pigmentosa. Arch Ophthalmol. 2008 Mar;126(3):337-40.

[6] Haim M, Holm NV, Rosenberg T. Prevalence of retinitis pigmentosa and allied disorders in Denmark. I Main results. Acta Ophthalmol (Copenh). 1992 Apr;70(2):178-86.

Scroll to top